HAS
46
-4
EXR
59
4
KLAC
71
4
AMG
55
3
CSCO
64
3
AMGN
59
4
ADBE
49
4
TGT
57
-2
D
53
2
TEL
88
5
APA
27
2
DFS
68
6
AME
63
3
INTU
72
3
PLD
48
-8
ADM
36
-4
WFC
74
2
UHS
66
2
WDC
57
3
CPB
47
-2
HAS
46
-4
EXR
59
4
KLAC
71
4
AMG
55
3
CSCO
64
3
AMGN
59
4
ADBE
49
4
TGT
57
-2
D
53
2
TEL
88
5
APA
27
2
DFS
68
6
AME
63
3
INTU
72
3
PLD
48
-8
ADM
36
-4
WFC
74
2
UHS
66
2
WDC
57
3
CPB
47
-2
Financhill
Back

Ultragenyx Pharmaceutical Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
42.84
Seasonality Move:
12.29%
Sell
50

SRPT
Sarepta Therapeutics

Last Price:
131.83
Seasonality Move:
8.89%
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $41.12. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $132.50. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $41.12
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $132.50
    The current trend is moderately bullish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.38 Sell
Relative Strength Index (14 RSI): 36.17 Sell
Chaikin Money Flow: -526969 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (41.16 - 45.34) Sell
Bollinger Bands (100): (43.31 - 49.39) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 2.38 Buy
Relative Strength Index (14 RSI): 60.06 Buy
Chaikin Money Flow: -529387 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (119.82 - 133.16) Buy
Bollinger Bands (100): (111.37 - 133.05) Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.46 Sell
20-day SMA: 42.72 Sell
50-day SMA: 45.61 Sell
200-day SMA: 42.06 Sell
8-day EMA: 41.51 Sell
20-day EMA: 42.79 Sell
50-day EMA: 44.59 Sell
200-day EMA: 44.26 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 133.09 Sell
20-day SMA: 128.08 Buy
50-day SMA: 125.92 Buy
200-day SMA: 113.27 Buy
8-day EMA: 132.09 Buy
20-day EMA: 129.71 Buy
50-day EMA: 126.49 Buy
200-day EMA: 117.96 Buy

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.46 per share, an increase next quarter of $0.08 per share, an increase this year of $0.87 per share, and an increase next year of $1.24 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.06 per share, an increase next quarter of $1.31 per share, an increase this year of $6.16 per share, and an increase next year of $6.01 per share.

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):